Shattuck is a biotechnology company developing a potentially first-in-class antibody for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory autoimmune diseases. Shattuck's expertise in protein engineering and commitment to pursuing the development of novel therapeutics targeting TNF receptors come together in its lead program, SL-325, a first-in-class DR3 antagonist antibody designed to achieve complete and more durable blockade of the clinically validated TL1A/DR3 pathway. Shattuck has offices in both Austin, Texas, and Durham, North Carolina.
Looking for a particular Shattuck Labs employee's phone or email?
Shattuck Labs Questions
The Shattuck Labs annual revenue was $9 million in 2026.
Andrew Neill is the CFO of Shattuck Labs.
46 people are employed at Shattuck Labs.
Shattuck Labs is based in Austin, Texas.
The NAICS codes for Shattuck Labs are [5417, 541, 54, 541714, 54171].
The SIC codes for Shattuck Labs are [87, 873].
Top Shattuck Labs Employees
-
Andrew Neill
Chief Financial Officer at Shattuck Labs
Austin, TX, US22 -
Casi Deyoung
Chief Business Officer at Shattuck Labs
Austin, TX, US35+ -
Suresh de Silva
Chief Scientific Officer at Shattuck Labs
Chapel Hill, NC, US14 -
Amy Franke
Vice President, Clinical Operations at Shattuck Labs
Boulder, CO, US35+ -
Tom Lampkin
Sr Vice President at Shattuck Labs
Raleigh, NC, US35+ -
15
-
Vishruti Makani
Director, Cell Sciences at Shattuck Labs
Chapel Hill, NC, US54
Related Companies
